Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,511,833
-
Total 13F shares
-
16,881,896
-
Share change
-
+16,881,896
-
Total reported value
-
$490,834,435
-
Price per share
-
$29.34
-
Number of holders
-
35
-
Value change
-
+$490,834,327
-
Number of buys
-
35
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q2 2021
As of 30 Jun 2021 Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,881,896 shares of stock of the company.
Largest 10 holders included FMR LLC, Casdin Capital, LLC, SB Management Ltd, Avidity Partners Management LP, Logos Global Management LP, RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., FEDERATED HERMES, INC., ORBIMED ADVISORS LLC, and Octagon Capital Advisors LP.
This table shows 35 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.